1332TiPTWO PHASE III STUDIES EVALUATING CERITINIB IN...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

1332TiPTWO PHASE III STUDIES EVALUATING CERITINIB IN PATIENTS (PTS) WITH ANAPLASTIC LYMPHOMA KINASE (ALK)-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC): ASCEND-4 AND ASCEND-5

Shaw, A., Tan, D.S.W., Crinò, L., Felip, E., Mok, T.S.K., Nishio, M., Paz-Ares, L., Scagliotti, G., Spigel, D.R., Wolf, J., Wu, Y., Castro, G., Sen, P., Zheng, C., Joe, A., Soria, J-C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu349.111
Date:
September, 2014
File:
PDF, 68 KB
2014
Conversion to is in progress
Conversion to is failed